Advertisement
Screener

Tempest Therapeutics, Inc. (TPST) Inventory Write-down

2.8 / 5 stars · 68/120 Roast Me

Tempest Therapeutics, Inc. Inventory Write-down

Tempest Therapeutics, Inc. (TPST) reported Inventory Write-down of $400.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-02.

Discontinued › Expense Statement › Operating Expenses

us-gaap:InventoryWriteDown · last filed 2017-03-02

  • Tempest Therapeutics, Inc. inventory write-down for the quarter ending 2015-12-31 was $500.00K.
  • Tempest Therapeutics, Inc. inventory write-down for the quarter ending 2015-09-30 was $400.00K.
  • Tempest Therapeutics, Inc. inventory write-down for fiscal 2016 was $400.00K.
Period endInventory Write-down 3 monthInventory Write-down 6 monthInventory Write-down 12 month
2016-12-31$400.00K
10-K · filed 2017-03-02
2015-12-31$500.00K
10-K · filed 2016-02-26
$900.00K
derived: sum of 2 quarters · filed 2016-02-26
2015-09-30$400.00K
10-K · filed 2016-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
BIOVIE INC. (BIVI)United States$0.012B
MUSTANG BIO, INC. (MBIO)United States$0.013B
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B